Michelle Gee
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 0.5%
- Dementia and Cognitive Impairment Research
- Epilepsy research and treatment
Papers in
-
- Dementia and Cognitive Impairment Research 5
- Epilepsy research and treatment 3
- Electroconvulsive Therapy Studies 3
-
- Alzheimer's disease research and treatments 5
- Pain Mechanisms and Treatments 3
- Co-authors
- Michael C. Irizarry (10 shared papers)Michio Kanekiyo (9 shared papers)Shobha Dhadda (9 shared papers)Christopher H. van Dyck (3 shared papers)Lynn D. Kramer (8 shared papers)Chad J. Swanson (3 shared papers)Takeshi Iwatsubo (2 shared papers)David Watson (1 shared paper)
- Journals
- Alzheimer s & Dementia (6 papers)Journal of Psychopharmacology (3 papers)Neuroscience (2 papers)SLAS DISCOVERY (2 papers)Epilepsia (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Michelle Gee
26 papers receiving 4.0k citations
Michelle Gee's Hit Papers
Peers
Comparison fields: 5 of 141
- Biological Psychiatry 230
- Psychiatry and Mental health 1.1k
- Physiology 1.4k
- Neurology 423
- Pharmacology 460
Countries citing papers authored by Michelle Gee
This map shows the geographic impact of Michelle Gee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Gee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Gee more than expected).
Fields of papers citing papers by Michelle Gee
This network shows the impact of papers produced by Michelle Gee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Gee. The network helps show where Michelle Gee may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle Gee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lecanemab in Early Alzheimer’s Disease Hit paper breakdown → | 2022 | 3045 |
| 2 | 2004 | 154 | |
| 3 | 2012 | 96 | |
| 4 | 2014 | 88 | |
| 5 | Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease Hit paper breakdown → | 2024 | 78 |
| 6 | 1996 | 77 | |
| 7 | 2019 | 73 | |
| 8 | 2011 | 72 | |
| 9 | 2012 | 67 | |
| 10 | 2023 | 52 | |
| 11 | 2005 | 51 | |
| 12 | 2009 | 49 | |
| 13 | 2008 | 46 | |
| 14 | 1997 | 40 | |
| 15 | 2013 | 32 | |
| 16 | 1999 | 20 | |
| 17 | 2014 | 20 | |
| 18 | 2022 | 19 | |
| 19 | 2023 | 17 | |
| 20 | 2025 | 4 |
About Michelle Gee
Michelle Gee is a scholar working on Psychiatry and Mental health, Physiology, Pharmacology, Biological Psychiatry and Molecular Biology, having authored 27 papers that have together received 4.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (5 papers), Dementia and Cognitive Impairment Research (5 papers), Tryptophan and brain disorders (4 papers), Epilepsy research and treatment (3 papers), Treatment of Major Depression (3 papers), Pain Mechanisms and Treatments (3 papers), Electroconvulsive Therapy Studies (3 papers) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Biological Psychiatry (230 citations), Psychiatry and Mental health (1.1k citations), Physiology (1.4k citations), Neurology (423 citations) and Pharmacology (460 citations). Michelle Gee has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Michael C. Irizarry, Michio Kanekiyo, Shobha Dhadda, Christopher H. van Dyck, Lynn D. Kramer, Chad J. Swanson, Takeshi Iwatsubo, David Watson, Randall J. Bateman and Paul Aisen. Their work appears in journals such as Alzheimer s & Dementia, Journal of Psychopharmacology, Neuroscience, SLAS DISCOVERY and Epilepsia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.